Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02275208 · ClinicalTrials.gov registry record

A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure

A clinical trial of Obesity, sponsored by Medtronic - MITG.

Completed
Registry status
120
Enrollment target
7
Study locations

NCT02275208 is a study of Obesity that has completed, run by Medtronic - MITG. The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02275208, a study of Obesity, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
120 participants
Enrollment target
7
Study locations

Study Summary

This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure. Subjects who meet the eligibility criteria will be considered for study participation and will be followed through 12 months.

Conditions Studied

Interventions

  • PROCEDURE SIPS the stomach, intestinal, pylorus, sparing procedure

Study Locations (7)

New York

  • - Mount Kisco
  • - New York

North Carolina

  • - Cary
  • - Durham

Colorado

  • - Parker

Florida

  • Florida Hospital Celebration Health - Celebration

Utah

  • - Salt Lake City

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2014-12-11
Est. Completion 2017-01-18

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT02275208

The ClinicalTrials.gov registry entry for NCT02275208 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which SIPS the stomach, intestinal, pylorus, sparing procedure is the first listed.

NCT02275208 reports 7 study locations spanning 5 distinct geographic areas - top geographies include New York, North Carolina, Colorado.

Frequently Asked Questions

What is clinical trial NCT02275208 about?

NCT02275208 is a clinical study titled "A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure". This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure. Subjects who meet the eligibility criteria will be considered for study participation and will be followed through 12 months.

What is the current status of trial NCT02275208?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-12-11. Estimated completion is 2017-01-18.

What conditions does trial NCT02275208 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02275208?

The interventions under investigation include: SIPS the stomach, intestinal, pylorus, sparing procedure (PROCEDURE).

Who is sponsoring clinical trial NCT02275208?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02275208 being conducted?

This trial has 7 study locations across Colorado, Florida, New York, North Carolina, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.